Fully automated radiosynthesis of N1-[18F]fluoroethyl-tryptophan and study of its biological activity as a new potential substrate for indoleamine 2,3-dioxygenase PET imaging
Tryptophan; PET imaging; Indoleamine 2,3-dioxygenase; 1-(2-[18F]fluoroethyl)tryptophan; Fully automated radiosynthesis; FASTlab
Abstract :
[en] Introduction:
Indoleamine 2,3-dioxygenase (IDO) catalyzes the initial step in the catabolism of L-tryptophan along the kynurenine pathway and exerts immunosuppressive properties in inflammatory and tumor tissues by blocking locally T-lymphocyte proliferation. Recently, 1-(2-[19F]fluoroethyl)-DL-tryptophan (1-[19F]FE-DL-Trp) was reported as a good and specific substrate of this enzyme. Herein, the radiosynthesis of its radioactive isotopomer (1-[18F]FE-DL-Trp, DL-[18F]5) is presented along with in vitro enzymatic and cellular uptake studies.
Methods:
The one-pot n.c.a. radiosynthesis of this novel potential PET imaging tracer, including HPLC purification and formulation, has been fully automated on a FASTlabTM synthesizer. Chiral separation of both isomers and their formulation were implemented on a second cassette. In vitro enzymatic and cellular uptake studies were then conducted with the D-, L- and DL-radiotracers.
Results:
The radiolabeling of the tosylate precursor was performed in DMF (in 5 min; RCY: 57% (d.c.), n=3). After hydrolysis, HPLC purification and formulation, DL-[18F]5 was obtained with a global radiochemical yield of 18±3% (not decay corrected, n=7, in 80 min) and a specific activity of 600±180 GBq/µmol (n=5). The subsequent separation of L- and D-enantiomers was performed by chiral HPLC and both were obtained after formulation with a RCY (d.c.) of 6.1% and 5.8%, respectively. In vitro enzymatic assays reveal that L-[18F]5 is a better substrate than D-[18F]5 for human IDO. In vitro cellular assays show an IDO-specific uptake of the racemate varying from 30% to 50% of that of L-[18F]5, and a negligible uptake of D-[18F]5.
Conclusion:
In vitro studies show that L-[18F]5 is a good and specific substrate of hIDO, while presenting a very low efflux. These results confirm that L-[18F]5 could be a very useful PET radiotracer for IDO expressing cells in cancer imaging.
Research Center/Unit :
GIGA CRC (Cyclotron Research Center) In vivo Imaging-Aging & Memory - ULiège
Disciplines :
Chemistry
Author, co-author :
Henrottin, Jean ; Université de Liège > Centre de recherches du cyclotron
Lemaire, Christian ; Université de Liège > Centre de recherches du cyclotron
Plenevaux, Alain ; Université de Liège > Centre de recherches du cyclotron
Franci, Xavier
Goldman, Serge
Luxen, André ; Université de Liège > Département de chimie (sciences) > Laboratoire de chimie organique de synthèse
Language :
English
Title :
Fully automated radiosynthesis of N1-[18F]fluoroethyl-tryptophan and study of its biological activity as a new potential substrate for indoleamine 2,3-dioxygenase PET imaging
scite shows how a scientific paper has been cited by providing the context of the citation, a classification describing whether it supports, mentions, or contrasts the cited claim, and a label indicating in which section the citation was made.
Bibliography
Uyttenhove C., Pilotte L., Theate I., Stroobant V., Colau D., Parmentier N., et al. Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase. Nat Med 2003, 9:1269-1274.
Macchiarulo A., Camaioni E., Nuti R., Pellicciari R. Highlights at the gate of tryptophan catabolism: a review on the mechanisms of activation and regulation of indoleamine 2,3-dioxygenase (IDO), a novel target in cancer disease. Amino Acids 2009, 37:219-229.
Theate I., van Baren N., Pilotte L., Moulin P., Larrieu P., Renauld J.-C., et al. Extensive profiling of the expression of the indoleamine 2,3-dioxygenase 1 protein in normal and tumoral human tissues. Cancer Immunol Res 2015, 3:161-172.
Dounay A.B., Tuttle J.B., Verhoest P.R. Challenges and opportunities in the discovery of new therapeutics targeting the kynurenine pathway. J Med Chem 2015, 58:8762-8782.
Henrottin J., Zervosen A., Lemaire C., Sapunaric F., Laurent S., Van den Eynde B., et al. N1-fluoroalkyltryptophan analogues: synthesis and in vitro study as potential substrates for indoleamine 2,3-dioxygenase. ACS Med Chem Lett 2015, 6:260-265.
van Baren N., Van den Eynde B.J. Tryptophan-degrading enzymes in tumoral immune resistance. Front Immunol 2015, 6:34.
Mellor A.L., Munn D.H. Tryptophan catabolism and T-cell tolerance: immunosuppression by starvation?. Immunol Today 1999, 20:469-473.
Munn D.H., Mellor A.L. IDO and tolerance to tumors. Trends Mol Med 2004, 10:15-18.
Sun T., Tang G., Tian H., Wang X., Chen X., Chen Z., et al. Radiosynthesis of 1-[18F]fluoroethyl-L-tryptophan as a novel potential amino acid PET tracer. Appl Radiat Isot 2012, 70:676-680.
Lemaire C., Libert L., Franci X., Genon J.-L., Kuci S., Giacomelli F., et al. Automated production at the curie level of no-carrier-added 6-[18F]fluoro-L-dopa and 2-[18F]fluoro-L-tyrosine on a FASTlab synthesizer. J Label Compd Radiopharm 2015, 58:281-290.
Damont A., Hinnen F., Kuhnast B., Schöllhorn-Peyronneau M.-A., James M., Luus C., et al. Radiosynthesis of [18F]DPA-714, a selective radioligand for imaging the translocator protein (18 kDa) with PET. J Label Compd Radiopharm 2008, 51:286-292.
Pilotte L., Larrieu P., Stroobant V., Colau D., Dolusic E., Frederick R., et al. Reversal of tumoral immune resistance by inhibition of tryptophan 2,3-dioxygenase. Proc Natl Acad Sci 2012, 109:2497-2502.
Hamacher K., Coenen H.H., Stöcklin G. Efficient stereospecific synthesis of no-carrier-added 2-[18F]-fluoro-2-deoxy-D-glucose using aminopolyether supported nucleophilic substitution. J Nucl Med 1986, 27:235-238.
Brenner M., Sailer E., Kocher V. Eine einfache enzymatische Methode zur herstellung von D- und L-tryptophan. Helv Chim Acta 1948, 31:1908-1914.
Chibata I., Yamada S., Yamada S. Studies on amino acids. IV. studies on the enzymatic resolution (III): enzymatic resolution of DL-tryptophan. Bull Agric Chem Soc Japan 1957, 21:62-66.
Mzengeza S., Venkatachalam T.K., Rajagopal S., Diksic M. Synthesis of enantiomercally pure alpha-[14C]methyl-L-tryptophan. Appl Radiat Isot 1993, 44:1167-1172.
Capece L., Lewis-Ballester A., Yeh S.-R., Estrin D.A., Marti M.A. The complete reaction mechanism of indoleamine 2,3-dioxygenase as revealed by QM/MM simulations. J Phys Chem B 2012, 116:1401-1413.
Similar publications
Sorry the service is unavailable at the moment. Please try again later.
This website uses cookies to improve user experience. Read more
Save & Close
Accept all
Decline all
Show detailsHide details
Cookie declaration
About cookies
Strictly necessary
Performance
Strictly necessary cookies allow core website functionality such as user login and account management. The website cannot be used properly without strictly necessary cookies.
This cookie is used by Cookie-Script.com service to remember visitor cookie consent preferences. It is necessary for Cookie-Script.com cookie banner to work properly.
Performance cookies are used to see how visitors use the website, eg. analytics cookies. Those cookies cannot be used to directly identify a certain visitor.
Used to store the attribution information, the referrer initially used to visit the website
Cookies are small text files that are placed on your computer by websites that you visit. Websites use cookies to help users navigate efficiently and perform certain functions. Cookies that are required for the website to operate properly are allowed to be set without your permission. All other cookies need to be approved before they can be set in the browser.
You can change your consent to cookie usage at any time on our Privacy Policy page.